Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)
China
· Delayed Price · Currency is CNY 4.900
+0.100 (2.08%)
At close: Mar 10, 2026
SHE:002793 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,202 | 4,055 | 5,829 | 8,342 | 15,181 | 15,215 | Upgrade
|
| Market Cap Growth | 29.29% | -30.44% | -30.12% | -45.05% | -0.22% | - | Upgrade
|
| Enterprise Value | 6,162 | 5,305 | 6,876 | 11,056 | 16,161 | 15,869 | Upgrade
|
| Last Close Price | 4.90 | 3.82 | 5.36 | 7.67 | 10.34 | 10.29 | Upgrade
|
| PE Ratio | - | - | - | - | 37.38 | 47.44 | Upgrade
|
| PS Ratio | 2.09 | 1.53 | 2.47 | 2.33 | 2.34 | 2.50 | Upgrade
|
| PB Ratio | 3.40 | 2.78 | 2.27 | 2.52 | 3.21 | 3.50 | Upgrade
|
| P/TBV Ratio | 5.28 | 4.54 | 2.93 | 3.00 | 3.76 | 4.13 | Upgrade
|
| P/FCF Ratio | 21.62 | - | 25.97 | - | - | - | Upgrade
|
| P/OCF Ratio | 18.27 | - | 12.49 | - | 125.85 | - | Upgrade
|
| EV/Sales Ratio | 2.47 | 2.00 | 2.91 | 3.08 | 2.50 | 2.60 | Upgrade
|
| EV/EBITDA Ratio | 123.53 | - | - | - | 22.90 | 27.03 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 31.10 | 38.11 | Upgrade
|
| EV/FCF Ratio | 25.60 | - | 30.63 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.91 | 1.12 | 0.59 | 1.10 | 0.60 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 28.00 | - | - | - | 3.97 | 2.47 | Upgrade
|
| Debt / FCF Ratio | 5.80 | - | 6.77 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.58 | 0.81 | 0.32 | 0.66 | 0.17 | 0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | 23.93 | -4.14 | -2.86 | -1.56 | 1.17 | 0.28 | Upgrade
|
| Net Debt / FCF Ratio | 3.67 | -4.33 | 3.68 | -1.91 | -4.37 | -0.42 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.36 | 0.41 | 0.75 | 0.80 | Upgrade
|
| Inventory Turnover | 3.02 | 3.51 | 2.35 | 3.86 | 4.77 | 4.11 | Upgrade
|
| Quick Ratio | 0.58 | 0.48 | 0.79 | 0.85 | 1.34 | 1.34 | Upgrade
|
| Current Ratio | 0.81 | 0.70 | 1.08 | 1.08 | 1.59 | 1.65 | Upgrade
|
| Return on Equity (ROE) | -38.06% | -52.20% | -26.16% | -31.26% | 9.28% | 8.20% | Upgrade
|
| Return on Assets (ROA) | -2.17% | -6.31% | -4.53% | -11.35% | 3.77% | 3.43% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.81% | -15.79% | -10.81% | -28.99% | 8.96% | 8.54% | Upgrade
|
| Return on Capital Employed (ROCE) | -8.00% | -26.50% | -15.00% | -42.70% | 9.50% | 8.80% | Upgrade
|
| Earnings Yield | -13.02% | -23.81% | -11.34% | -14.68% | 2.67% | 2.11% | Upgrade
|
| FCF Yield | 4.63% | -6.74% | 3.85% | -13.59% | -1.24% | -2.59% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.29% | 0.49% | Upgrade
|
| Payout Ratio | - | - | - | - | 32.59% | 42.43% | Upgrade
|
| Buyback Yield / Dilution | 0.78% | 2.11% | 23.91% | 1.79% | 0.51% | -31.07% | Upgrade
|
| Total Shareholder Return | 0.78% | 2.11% | 23.91% | 1.79% | 0.80% | -30.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.